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To evaluate the ability of longitudinal Useful Field of View (UFOV) and simulated driving
measurements to predict future occurrence of motor vehicle collision (MVC) in drivers with
glaucoma.
Design
Prospective observational cohort study.
Participants
117 drivers with glaucoma followed for an average of 2.1 ± 0.5 years.
Methods
All subjects had standard automated perimetry (SAP), UFOV, driving simulator, and cogni-
tive assessment obtained at baseline and every 6 months during follow-up. The driving sim-
ulator evaluated reaction times to high and low contrast peripheral divided attention stimuli
presented while negotiating a winding country road, with central driving task performance
assessed as “curve coherence”. Drivers with MVC during follow-up were identified from
Department of Motor Vehicle records.
Main OutcomeMeasures
Survival models were used to evaluate the ability of driving simulator and UFOV to predict
MVC over time, adjusting for potential confounding factors.
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Results
Mean age at baseline was 64.5 ± 12.6 years. 11 of 117 (9.4%) drivers had a MVC during fol-
low-up. In the multivariable models, low contrast reaction time was significantly predictive of
MVC, with a hazard ratio (HR) of 2.19 per 1 SD slower reaction time (95% CI, 1.30 to 3.69;
P = 0.003). UFOV divided attention was also significantly predictive of MVC with a HR of
1.98 per 1 SD worse (95% CI, 1.10 to 3.57; P = 0.022). Global SAP visual field indices in the
better or worse eye were not predictive of MVC. The longitudinal model including driving
simulator performance was a better predictor of MVC compared to UFOV (R2 = 0.41 vs R2 =
0.18).
Conclusions
Longitudinal divided attention metrics on the UFOV test and during simulated driving were
significantly predictive of risk of MVC in glaucoma patients. These findings may help
improve the understanding of factors associated with driving impairment related to
glaucoma.
Introduction
Driving is the primary source of transportation in many countries and is therefore considered
an instrumental activity of daily living for many people. [1] Previous studies have shown that
ability to drive is intimately related to health-related quality of life, [2–5] with driving cessation
associated with increased risk of depression, social isolation and entry into residential care.
[2,4] On the other hand, driving is a highly visual task, and continued driving in the presence
of significant visual impairment is likely to be associated with increased risk of motor vehicle
collisions (MVC), with potentially serious implications for the individual and society. [6–11]
Glaucoma is a leading cause of visual impairment in the world. [12] Previous studies have
shown that drivers with glaucoma are at increased risk of MVC. [13–17] Haymes and col-
leagues reported drivers with glaucoma to be over 6 times more likely to have been involved in
a MVC compared to similarly aged controls. [13] However, previous studies have shown only a
weak association between MVC and visual field defects as assessed by standard automated
perimetry (SAP). [13–19] In SAP, the ability to detect a static white-on-white peripheral visual
stimulus at threshold is evaluated under optimal conditions of adaptation and testing. How-
ever, these artificial test conditions minimize potential distractions and may give unrealistic
estimates of the amount of useful vision that is available to a complex task such as driving.
In contrast to the traditional visual field test, an assessment of visual performance under
conditions of divided attention would better reflect the demands imposed by driving, when
subjects are frequently required to detect or monitor a peripheral stimulus, while simulta-
neously attending to a central task. [20–23] The Useful Field of View (UFOV) test (Visual
Awareness, Inc, Chicago, IL) is a computer-based assessment developed to evaluate processing
speed under conditions of divided attention and previous studies have suggested this test to be
a useful predictor of risk of MVC. [21,22,24–26] In addition, the ability to divide attention may
also be tested under simulated scenarios using driving simulators. By more closely reproducing
the demands of real world driving, driving simulators may potentially allow better estimation
of risk. [27]
In glaucoma patients, the relationship between MVC and measurements of divided atten-
tion from UFOV and driving simulation has only been evaluated using retrospective data.
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[19,25] Therefore, although studies have reported impaired ability to divide attention to be
associated with increased odds of a history of MVC, their retrospective design did not allow for
prediction of individual risk. Furthermore, patients may behave differently on UFOV or driv-
ing simulation after occurrence of a MVC due to modified driving behaviours, leading to diffi-
culties in establishing a causal relationship. A further limitation of previous studies is that
UFOV and simulation data were acquired only at a single point in time. It is possible that longi-
tudinal changes on these tests could provide even stronger predictive ability compared to single
point observations. To our knowledge, such prospective assessment of the relationship between
longitudinal changes on divided attention tests and risk of MVC has not been yet evaluated in
patients with glaucoma.
The purpose of the current study was to determine whether longitudinal UFOV and driving
simulator measures were predictive of risk of MVC in a cohort of glaucomatous subjects fol-
lowed over time. In addition, we compared the predictive ability of these tests to those of stan-
dard functional assessments conducted in this population.
Methods
This was a longitudinal observational cohort study. Subjects were recruited as part of the Diag-
nostic Innovations in Glaucoma Study: Functional Impairment, conducted at the Visual Per-
formance Laboratory, Department of Ophthalmology, University of California San Diego
(UCSD). Written informed consent was obtained from all participants, and the institutional
review board and human subjects committee at the UCSD prospectively approved all methods.
All study methods adhered to the tenets of the Declaration of Helsinki for research involving
human subjects and the study was conducted in accordance with the regulations of the Health
Insurance Portability and Accountability Act.
At each visit during follow-up, patients underwent a comprehensive ophthalmologic exami-
nation, review of medical history, contrast sensitivity assessment using the Pelli-Robson con-
trast sensitivity chart (Precision Vision, La Salle, IL), stereoscopic optic disc photograph (Kowa
NonmydWX3D, Kowa Optimed, Inc, Torrance, CA), and SAP using the Swedish interactive
threshold algorithm (SITA Standard 24–2, Carl Zeiss Meditec, Inc., Dublin, CA, USA). Only
patients with open angles on gonioscopy were included. Subjects were excluded if they had any
other ocular or systemic disease that could affect the optic nerve or the visual field. Subjects
also completed a Montreal Cognitive Assessment (MOCA), which is a test developed to detect
mild cognitive impairment, similar to the Mini-Mental State Examination. [28]
Glaucoma was defined by the presence of repeatable ( 3 consecutive) abnormal SAP tests.
Eyes with documented evidence of progressive glaucomatous optic disc changes noted on
masked grading of stereophotographs were also classified as glaucomatous, regardless of visual
field findings. SAP tests were defined as abnormal if they had a pattern standard deviation with
P<0.05 and/or a glaucoma hemifield test result outside normal limits. Visual fields with more
than 33% fixation losses or false-negative errors, or more than 15% false-positive errors, were
excluded. In order to evaluate binocular visual field loss, sensitivities of the monocular SAP
tests of the right and left eyes were combined to calculate an integrated binocular visual field.
The sensitivity for each point of the binocular visual field was estimated using the binocular
summation model described by Nelson-Quigg et al. [29]
Useful Field of View (UFOV)
The UFOV was used to assess visual processing speed (in milliseconds [ms]) under divided
attention. Details of the test have been provided previously. [24–26] In brief, participants were
asked to identify a silhouette of a 2 cm by 1.5 cm truck or car (2 choices), that appeared in a
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box on the center of a 17-inch touchscreen monitor, in addition to a concurrent peripheral
localization task (an image of a car presented on one of eight radial spokes at a fixed eccentric-
ity of approximately 11 degrees). The subject was then asked to identify the central target and
to identify on which spoke the outside object was located. The test proceeded with decreasing
presentation times, ranging from 500 ms to 17 ms, until the presentation time that would result
in a 75% accurate response could be recorded. All stimulus presentations were at maximum
contrast for UFOV divided attention task. All subjects had prior experience with the UFOV
test, having performed at least one test previously.
Driving Simulation
The ability to divide attention was also assessed by measuring reaction times to stimuli pre-
sented during a divided attention protocol during simulated driving. Details of the methodol-
ogy employed for driving simulation have been provided previously.7, [30] The test evaluated
the ability to attend simultaneously to a central visual task of driving (negotiating curves on a
winding country road for 4 minutes) and to a peripheral visual task of perceiving a projected
stimulus and responding by pushing a button on the steering wheel. The peripheral stimuli
were presented at about 20-degrees of visual angle in the upper right and upper left of the simu-
lator screen. The contrast of the stimulus was altered using alpha blending techniques to
achieve symbol transparencies of 0.1 and 0.9. Therefore in the case of 0.1 symbol transparency,
the symbol intensity and color that the driver perceived was 10% of the symbol intensity and
color and 90% of the background intensity and color. The equivalent Michelson contrasts were
0.04 and 0.27 for low- and high-contrast stimuli, respectively. At maximum screen intensity
the divided attention stimulus symbols were pure white, while the background was constant
and consisted of a cloudy sky. Examples of the size and shape of targets has been presented in
detail elsewhere. [19,30] For each contrast level, there were an average of 5 stimuli presented
which stayed on the screen for a maximum of 3 to 6 seconds (uniform distribution) or until the
driver responded. The next stimuli appeared between 3 and 6 seconds (again uniform distribu-
tion) after the driver responded or when the maximum display time had elapsed.
The main outcome measure of reaction time was defined as the time interval between
appearance of the peripheral stimulus and the subject pressing the button on the steering
wheel, with a longer reaction time indicating worse result. Reaction times have been extensively
used in the psychophysical literature for investigation of visual processing speed. [27,31] The
mean reaction time was calculated by averaging the reaction time for all presentations at spe-
cific contrast levels (low and high). We denominated these metrics as “low contrast reaction
time” and “high contrast reaction time”. A false positive percentage was calculated, defined as
the number of button presses occurring when no stimulus had been presented divided by the
total number of stimuli presented. [30]
The overall reaction time to a visual stimulus may also be influenced by the motor response
(the act of pressing a button). However, it is expected that the motor response contribution to
the reaction time will be similar to different contrast presentations. The difference in reaction
times to detect two stimuli under different contrasts should depend essentially on the ability of
the visual system to detect the stimuli, while the motor response to press the button should stay
essentially the same once the stimulus is detected. Therefore, we subtracted the overall reaction
times from the low and high contrast stimuli in order to isolate the visual processing speed con-
tribution to the overall reaction time. We denoted this metric as “corrected reaction time”.
As a patient might achieve fast reaction times to peripheral stimuli by adopting a strategy
in which the central driving task is neglected, it was important to assess central driving task
performance. [32] This was measured using “curve coherence”, which was defined as the
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normalized cross-correlation function between the road curvature (kroad) and the vehicle path











Where nwas the number of samples of the two signals and SD was the standard deviation of the
signals, with a coherence of 1 indicating the two signals to be an exact match. Themaximum coher-
ence is computed across all delay shifts. To minimize the effect of unreliable tests and learning
effect, all subjects underwent training prior to test commencement. Training consisted of a 2-min-
ute practice of acceleration and deceleration, followed by 1 minute of the curve negotiation task.
Follow-up and Definition of Study Endpoints
Subjects had UFOV and driving simulator tests performed at baseline and at every 6 months
during follow-up. Prospective information (i.e., after baseline) regarding incidence of MVC
during follow-up was obtained from the California Department of Motor Vehicles (DMV).
The study endpoint was defined as the date of MVC reported on the DMV records. To evaluate
whether longitudinal measurements were predictive of the study endpoints, only tests acquired
before the MVC event date were analysed in the study. Subjects who did not experience a MVC
were considered censored at the last follow-up visit. All tests up to the last available follow-up
date were analysed for these patients. In short, only performance assessment data collected
before an MVC was used in the analyses reported herein.
Statistical Analysis
The primary purpose of this study was to determine whether longitudinal driving simulator
metrics and UFOV divided attention tests were predictive of MVC in drivers with glaucoma.
Hazard ratios (HRs) for the association between potential predictive factors and MVC were
obtained by a Weibull survival model incorporating time-dependent covariates. [33] We report
univariable as well as multivariable models adjusting for age, degree of cognitive impairment
(MOCA score), severity of binocular visual field defect and average mileage driven per week.
As the magnitude of a hazard ratio for a particular variable depends on its unit of measure-
ment, a direct comparison of hazard ratios would be an inappropriate way of comparing the
ability of models in predicting risk of MVC. For this purpose, we used the modified R2 index
proposed by Royston, [34] which has previously been used for similar purposes. [35,36] The
modified R2 index is equivalent to the coefficient of determination of a linear model and mea-
sures the amount of variation in the outcome (survival time) explained by the predictors, or, in
other words, the strength of the relationship between the predictors and the outcome in a sur-
vival model. The modified R2 index has been proposed as the best way to assess prognostic
information of survival models. [37]
All statistical analyses were performed with commercially available software (Stata, version
13; StataCorp LP, College Station, TX.). The α level (type I error) was set at 0.05.
Results
The study included 117 subjects with glaucoma with a mean ± standard deviation age of
64.5 ± 12.6 years at baseline. Subjects were followed for an average of 2.1 ± 0.5 years with an
average of 3.1 ± 2.3 visits during follow-up. 11 patients (9.4%) had at least one MVC during fol-
low-up. Fig 1 illustrates the cumulative probability of having a MVC during the study. Table 1
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shows baseline demographic and clinical characteristics of subjects who had MVC versus those
who did not. At baseline, only the parameter measuring performance on the central driving
task (curve coherence) was significantly different between the two groups. The individual char-
acteristics of patient are shown in S1 Table.
Table 2 reports hazard ratios (HRs) for univariable models with 95% confidence intervals
(CI) for each putative predictive factor. In the univariable model, low contrast reaction time was
significantly associated with higher risk of MVC during follow-up. Each 1 standard deviation
(SD) slower low contrast reaction time was associated with a 57% increased risk of MVC
(HR = 1.57 per 1 SD slower; 95% CI, 1.07 to 2.29; P = 0.020). Slower corrected reaction time was
also associated with increased risk of MVC (HR = 1.57 per 1 SD larger; 95% CI, 1.08 to 2.30;
P = 0.019), as well as worse performance on the central driving task (curve coherence) (HR = 1.50
per 1 SD lower 95% CI, 1.17 to 1.92; P = 0.001). Additionally, slower performance on the UFOV
divided attention test (HR = 1.64 per 1SD slower; 95% CI, 1.01 to 2.65; P = 0.046) was associated
with an increased risk of MVC during follow-up. Binocular visual field mean sensitivity, better
eye MD, and worse eye MD were not associated with increased risk of MVC (Table 2).
Fig 1. Kaplan-Meier survival curve estimating the cumulative probability of motor vehicle collision during follow-up.
doi:10.1371/journal.pone.0138288.g001
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Table 3 shows multivariable HRs after adjusting for age, cognitive impairment (MOCA
score), binocular SAP sensitivity, and average mileage driven per week. Driving simulator met-
rics of low contrast reaction time and curve coherence remained significantly associated with
increased risk of MVC. Each 1 SD slower low contrast reaction time was associated with a 2.19
times increased risk of MVC (HR = 2.19 per 1 SD slower; 95% CI, 1.30 to 3.69; P = 0.003),
whereas each 1 SD lower curve coherence increased the risk by 1.36 times (HR = 1.36 per 1 SD
lower; 95% CI, 1.02 to 1.83; P = 0.039). The multivariable model including low contrast reac-
tion time and curve coherence had an R2 of 41% for predicting risk of MVC. Figs 2 and 3
shows cases of glaucoma patients with different outcomes predicted by the longitudinal evalua-
tion of driving simulator low contrast reaction times. Fig 2 shows a patient who demonstrated
progressively slower reaction times during follow-up. Predicted survival probabilities for this
patient were relatively low, indicating a relatively high risk of MVC. This subject in fact had a
DMV-reported MVC during follow-up. Fig 3 shows a patient with relatively faster and stable
reaction times, which resulted in high survival probabilities and low risk of MVC. This subject
did not show evidence of MVC during follow-up.
Slower UFOV divided attention time also remained associated with increased risk of MVC
in the multivariable model. Each 1 SD slower performance on the UFOV divided attention test
was associated with 1.98 times increased risk of MVC (HR = 1.98 per SD slower, 95% CI, 1.10
to 3.57; P = 0.022). The multivariable model including UFOV had a R2 of 18% in predicting
risk of MVC.
We also enrolled a group of 50 healthy subjects with normal optic disc evaluation and
normal SAP results. None of the controls had a motor vehicle collision during a follow-up
Table 1. Baseline demographic and clinical characteristics of study patients (mean ± standard deviation).
Variables No Motor Vehicle Collisions (106 subjects) Motor Vehicle Collisions (11 subjects) P-value
Age (years) 65.1 ± 12.0 58.5 ± 17.3 0.251
Sex, female (%) 42 (39.6%) 7 (63.6%) 0.198*
Ethnicity (%) 0.556*
Caucasian 67 (63.2%) 8 (72.7%)
African-American 26 (24.5%) 1 (9.1%)
Other 13 (12.3%) 2 (18.2%)
MD Worse Eye (dB) -3.4 ± 4.9 -3.5 ± 4.8 0.892
MD Better Eye (dB) -1.1 ± 2.8 -2.0 ± 3.8 0.365
Binocular SAP Sensitivity (dB) 29.0 ± 2.3 28.7 ± 3.0 0.933
Visual Acuity Worse Eye (LogMAR) 0.06 ± 0.15 0.12 ± 0.23 0.850
Visual Acuity Better Eye (LogMAR) -0.03 ± 0.11 -0.05 ± 0.11 0.588
Contrast Sensitivity Worse Eye 1.43 ± 0.21 1.40 ± 0.19 0.566
Contrast Sensitivity Better Eye 1.52 ± 0.15 1.49 ± 0.14 0.526
Average Distance Driven per Week (miles) 167 ± 224 178 ± 87 0.171
Montreal Cognitive Assessment Score 28 ± 3 28 ± 3 0.563
UFOV Divided Attention Test (ms) 71 ± 98 94 ± 149 0.785
Low Contrast Reaction Time (s) 0.94 ± 0.76 1.09 ± 1.37 0.929
High Contrast Reaction Time (s) 0.59 ± 0.19 0.58 ± 0.14 0.515
Corrected Reaction Time (s) 0.35 ± 0.70 0.51 ± 1.36 0.725
Curve Coherence 0.96 ± 0.01 0.91 ± 0.03 0.009
Abbreviations: MD = mean deviation, dB = decibels; logMAR = logarithm of the minimum angle of resolution; UFOV = Useful field of view;
ms = miliseconds, s = seconds.
*Fisher’s exact test.
doi:10.1371/journal.pone.0138288.t001
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period of 2.1 ± 0.5 years. At the last follow-up visit, patients with glaucoma had significantly
slower average low contrast reaction time on the simulator task compared to healthy subjects
(1.22 ± 1.07s vs 0.61 ± 0.20s, respectively; P<0.001). In addition they also had significantly
slower performance on the UFOV divided attention test (103 ± 129ms vs. 47 ± 57ms, respec-
tively; P = 0.006).
Discussion
This study has shown longitudinal performances on divided attention metrics to be indepen-
dently predictive of risk of MVC in drivers with glaucoma. Both UFOV and driving simulator
measures were predictive of MVC; however, after adjusting for confounding factors, driving
simulator tasks had superior predictive ability compared to UFOV. To our knowledge this is
the first longitudinal study to prospectively evaluate risk of MVC in drivers with glaucoma and
Table 2. Results of univariable models for prediction of motor vehicle collisions in glaucoma
patients.
Variables Hazard Ratio 95% CI P-value
Low contrast reaction time (per 1 SD slower) 1.57 1.07–2.29 0.020
High contrast reaction time (per 1 SD slower) 1.06 0.55–2.04 0.869
Corrected reaction time (per 1 SD larger) 1.57 1.08–2.30 0.019
Curve coherence (per 1 SD lower) 1.50 1.17–1.92 0.001
UFOV divided attention (per 1 SD slower) 1.64 1.01–2.65 0.046
MD worse eye (per 1 SD lower) 0.97 0.56–1.68 0.903
MD better eye (per 1 SD lower) 0.81 0.51–1.28 0.364
Binocular SAP sensitivity (per 1 SD lower) 0.93 0.52–1.69 0.820
Age (per 1 SD older) 0.64 0.40–1.04 0.069
Sex (Female) 2.90 0.85–9.93 0.089
Ethnicity (Caucasian) 1.43 0.38–5.38 0.600
Montreal Cognitive Assessment Score (per 1 SD lower) 1.11 0.59–2.11 0.742
Visual acuity worse eye (per 1 SD worse) 1.28 0.78–2.12 0.335
Visual acuity better eye (per 1 SD worse) 0.86 0.52–1.44 0.565
Contrast sensitivity worse eye (per 1 SD worse) 0.83 0.39–1.77 0.621
Contrast sensitivity better eye (per 1 SD worse) 0.87 0.50–1.52 0.621
Average mileage per week (per 1 SD further) 1.08 0.60–1.95 0.795
Abbreviations: SD = standard deviation.
doi:10.1371/journal.pone.0138288.t002
Table 3. Results of multivariable survival analyses examining the relationship between driving simulation and UFOVmetrics with risk of motor
vehicle collisions, after adjustment for confounding factors.
DRIVING SIMULATION USEFUL FIELD OF VIEW
HR 95% CI P-value HR 95% CI P-value
Low Contrast Reaction Time (per 1 SD slower) 2.19 1.30–3.69 0.003 UFOV Divided Attention (per 1 SD slower) 1.98 1.10–3.57 0.022
Curve Coherence (per 1 SD lower) 1.36 1.02–1.83 0.039
MOCA Score (per 1 SD lower) 1.40 0.66–2.96 0.386 MOCA Score (per 1 SD lower) 1.18 0.62–2.23 0.619
Binocular SAP sensitivity (per 1 SD lower) 0.88 0.44–1.76 0.714 Binocular SAP sensitivity (per 1 SD lower) 0.85 0.44–1.63 0.628
Age (per 1 SD older) 0.57 0.31–1.03 0.065 Age (per 1 SD older) 0.54 0.31–0.92 0.023
Average Mileage per Week (per 1 SD further) 1.30 0.71–2.38 0.399 Average Mileage per Week (per 1 SD further) 1.06 0.56–2.02 0.862
Abbreviations: SD = standard deviation; HR = Hazard Ratio.
doi:10.1371/journal.pone.0138288.t003
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the results provide evidence for the use of divided attention metrics as potential tools to assess
risk of driving impairment in this population.
At baseline, UFOV divided attention and driving simulator low contrast reaction times
were similar between MVC and no MVC groups, however drivers that went on to experience a
MVC had worse performance on the central driving task of following a curve in the road
(curve coherence). Worse central driving task performance was sustained during follow-up,
but a significant difference in driving simulator low contrast reaction times also emerged
between drivers with and without a MVC. Therefore, survival models incorporating longitudi-
nal divided attention metric data helped to predict future occurrence of MVC in a way that was
not possible using baseline metrics alone. Drivers who developed MVC also had larger cor-
rected reaction times on driving simulation, which indicates that the difference in performance
between groups was not likely to be due to differences in the motor response component of the
driving simulator reaction times. [30]
Previous studies have indicated that drivers with glaucoma are at increased risk of MVC
compared to those without the disease. [13],[30], [38], [39] Haymes et al [13] reported that the
Fig 2. Predicted survival probabilities for a glaucoma patient that had amotor vehicle collision during follow-up. This patient demonstrated
progressively slower reaction times during follow-up and relatively low predicted survival probabilities, indicating high risk of motor vehicle collision.
doi:10.1371/journal.pone.0138288.g002
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results of UFOV divided attention test were the strongest factor associated with MVC in glau-
comatous patients (adjusted odds ratio = 10.29; 95% CI, 1.10–96.62). However, these studies
relied on retrospective collection of MVC data and so were not able to assess the ability of dif-
ferent tests to predict risk of future MVC for individual patients. By prospectively collecting
longitudinal data from predictive tests and incidence of MVC, the present study has addressed
this limitation. The use of survival models allowed us to quantify the ability of the different
tests to predict MVC, while also taking into account the censored aspect of the data and adjust-
ing for the effect of confounding factors. Each 1 SD slower low contrast reaction time was asso-
ciated with a 2.19 times higher risk of MVC in a multivariable model adjusting for age, curve
coherence, MOCA score, binocular SAP and average distance driven per week. Furthermore,
these models allowed individual prediction of risk, as illustrated in Figs 2 and 3. A subject with
slower reaction times, as shown on Fig 2, was predicted to have a relatively higher risk (lower
survival probability) of MVC, compared to a subject with faster reaction times, as shown on
Fig 3. The use of longitudinal information allows updating the risk profile as patients are fol-
lowed over time, resulting in improved estimates of risk.
Fig 3. Predicted survival probabilities for a glaucoma patient that did not have amotor vehicle collision during follow-up. This patient demonstrated
stable and relatively fast reaction times during follow-up, which resulted in high predicted survival probabilities and low risk of motor vehicle collision.
doi:10.1371/journal.pone.0138288.g003
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Although the follow-up for the study was on average only 2.1 years, it is important to note
that when assessing a driver’s risk of MVC, it is in fact the relatively short-term risk that is of
most concern. In other words, it is more important to know if a driver has an increased risk of
an MVC occurring in the near term, such as in one to three years, so that appropriate measures
can be taken to mitigate the risk. The results of this study suggest that if one were to detect
worsening ability to perform the UFOV or driving simulator tasks, indicating increased risk of
MVC; one might be able to intervene to reduce risk. However, further studies are necessary to
determine the level of risk of MVC deemed acceptable for continued driving, and the appropri-
ateness of interventions to decrease risk, for example, restriction or revocation of driving
license. It is also important to examine the influence of drivers’ self-perceived risk of MVC, and
determine whether modifying driving behaviours, such as limiting driving in inclement
weather or at night might reduce risk in higher risk individuals.
In agreement with previous cross-sectional studies we found conventional measures of
visual function, including visual acuity and binocular SAP sensitivity had relatively low ability
to predict MVC. [25,27] A possible explanation is that tests such as SAP are performed under
artificial conditions and do not reflect the visual complexity of real-world driving. SAP is per-
formed under conditions of minimal visual distraction, whereas the ability to deal with visual
distractions, or to divide attention, is essential for most daily activities, including complex cog-
nitively demanding activities such as driving. It should be noted, however, that our study
included a relatively small proportion of patients with moderate or severe visual field damage.
In addition, it is possible that specific types of visual field defects might be associated with
increased risk of MVC. [40,41] For example, the study performed by Glen et al. showed that
simulated superior visual field defects had more impact than inferior defects on MVCs. [41]
The purpose of the current study was to validate driving simulator metrics that could be pre-
dictive of risk of real-life MVCs. Once these metrics are validated and can serve as surrogates
for risk of MVC, one can then investigate the impact of different conditions on these metrics,
such as how different patterns of visual field loss affect performance on the simulator metrics,
and this should be the subject of future studies.
A likely reason for the better ability of the driving simulator to predict MVCs was that it bet-
ter replicates the complexity of real driving situations, especially with inclusion of a divided
attention task. The driving simulator also allowed testing using a more demanding low contrast
divided attention stimuli, and the reaction times to low contrast stimuli were stronger predic-
tors of MVC than reaction times to high contrast stimuli. This supports the findings of Tatham
et al that drivers with glaucoma are affected more by low contrast tasks than similarly aged
controls. [30]
Our study had limitations. As MVCs are relatively rare events, there were only a relatively
small number of patients in the study who experienced a MVC during follow-up. The inci-
dence of MVCs in the included glaucomatous population was higher than in a group of healthy
subjects followed over time, a finding in agreement with previous studies. [42] Incidences of
MVCs in different studies may vary according to the characteristics of the population studied,
geographic location and methods of measurement, among other factors. However, to our
knowledge, our study was the first to prospectively evaluate risk of MVC in a well-defined
cohort of patients with glaucoma and we found statistically significant and clinically relevant
results for divided attention variables, despite the relatively small number of MVCs. Due to the
relative small numbers of MVCs in our cohort, it was also not possible to assess whether spe-
cific types or circumstances of MVCs were more common in patients with glaucoma and their
relationship with the metrics investigated. It is possible that some of the MVCs were underre-
ported to the DMV, especially minor incidents. According to California law, a driver must
report a collision only if the damage caused is greater than $750, and /or anyone was injured or
Predicting Collisions in Glaucoma
PLOSONE | DOI:10.1371/journal.pone.0138288 October 1, 2015 11 / 14
killed. However, use of DMV records is a useful method to reduce the potential for bias or
underreporting that may occur when such information is obtained by self-report. With regard
to the tests used to predict MVC evaluated in our study, it is important to note that driving
simulators have limitations, as although they provide realistic, standardized scenarios, drivers
may behave differently in real-world driving conditions. In addition, simulators may not be
readily available for testing in clinical practice. Despite this, our findings may serve to validate
driving simulation as a method for assessing driving impairment and also increase the under-
standing of the functional deficits that increase risk of MVC in patients with glaucoma. It is
important to note that we excluded patients with motion sickness who were unable to complete
driving simulation from the study. Motion sickness during driving simulation can potentially
confound data, influence participant dropout rates and also limit the effectiveness of the test
[43] [44] However, it is unlikely that this would have biased the results as there does not seem
to be a relationship between simulator sickness and risk of MVC.
Another limitation of our study is the potential for confounding effects caused by media
opacities, such as cataract. It is possible that cataract could result in worse performance on the
tests evaluated in the study and also in higher incidence of MVC. However, the presence of cat-
aract would likely be also detected by measurements of visual acuity, Pelli-Robson contrast sen-
sitivity and SAP MD. The lack of significant effect of these variables suggests that cataract did
not play a significant role as a confounder in our results.
In conclusion, this study found that longitudinal driving simulator metrics and UFOV
divided attention test were independent predictors of MVC in glaucoma patients. These find-
ings may have significant implications for the identification of drivers with glaucoma at high
risk of collisions and also for improving the understanding of driving impairment related to
the disease.
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